Cambridge Healthtech Institute’s Inaugural

Digital Health: Pharmaceutical Executive Summit

Clinical Utility and Emerging Applications in Drug Development, Diagnostics, and Healthcare

June 18-19, 2019


Digital Health is promising to revolutionize healthcare delivery, optimize personalized and precision medicine, and offer new tools for drug and diagnostic development. The applications of biosensors, mobile devices and wearables, Internet of Things, mobile health platforms, artificial intelligence, and digital biomarkers are quickly expanding into all areas of patient monitoring and disease management, point-of-care diagnostics, and digital endpoints in clinical trials. Cambridge Healthtech Institute’s Inaugural Digital Health: Pharmaceutical Executive Summit will bring together leading experts and thought leaders in digital health to discuss the latest technologies and implementation of digital tools into drug development, diagnostics and healthcare.

DIGITAL THERAPEUTICS

Digital Therapeutics in Pharma

Joris Van Dam, PhD, Head, Digital Therapeutics, Novartis Institutes for BioMedical Research

The Rise of Digital Therapeutics as Companions to Existing and Future Therapies

Pierre Leurent, CEO, Voluntis

Transforming Care Models and Business Models with Digital Medicine

David J. O’Reilly, Chief Platform Officer, Proteus Digital Health

Digital Health: Design for the Behavior You Would Like to See

Christian Theil Lundgaard, PhD, Director, Digital Health Partnerships & Commercial Strategy, Novo Nordisk

MOBILE HEALTH AND DIGITAL TOOLS FOR PATIENT-CENTRIC CLINICAL TRIALS

Virtual Clinical Trials, Empowering Patients and Create 20k Trial

Mohanad Fors, MBA, Co-Founder, Global Head of Biome - The Digital Innovation Lab by Novartis

Moving Beyond Patient Engagement to Human-Centered Design in Digital Health

Greg Silvesti, Head, Digital Health & Innovation, AbbVie

Making Trials More Attractive, Inclusive and Manageable with Innovative Use of Connected Devices: Case Studies and Lessons Learned from a Big Pharma Company

Bert Hartog, PhD, Senior Director, Clinical Innovation, Janssen Pharmaceutica N.V.

Utilizing Everyday Technologies to Accelerate Patient Recruitment and Engagement

Magdalena Schoeneich, Head, Takeda Digital Accelerator, R&D, Takeda

 

MOBILE HEALTH AT BIG PHARMA

Digital Health Opportunities 2025

Raj Pallapothu, mHealth Global Lead, Bayer

Breakthrough Digital - Making a Positive Impact on Millions of Patients

Adrian Chernoff, MBA, Former Worldwide Vice President, Global Head of Research and Development, Johnson and Johnson

BIG DATA: AI AND MACHINE LEARNING IN DIGITAL HEALTH

The Benefits of Migrating Digital Health Data to the Cloud

Tomasz Adamusiak, MD, PhD, Director, Medical Informatics Lead, Digital Medicine & Translational Imaging, Pfizer

Humanizing Care through AI

Kamal Jethwani, MD, MPH, Senior Director, Pivot Labs, Partners HealthCare; Assistant Professor, Harvard Medical School

Precision Healthcare through Multi-Scale Biomedical Data Integration

Jessilyn Pearl Dunn, PhD, Assistant Professor, Biomedical Engineering and Biostatistics & Bioinformatics, Duke University


For more details on the conference, please contact:
Julia Boguslavsky

Executive Director, Conferences

Cambridge Healthtech Institute

Email: juliab@healthtech.com

 

For partnering and sponsorship information, please contact:

Companies A-K
Rod Eymael
Business Development Manager
Cambridge Healthtech Institute

Phone: 781-247-6286
Email: reymael@healthtech.com

 

Companies L-Z
Joseph Vacca, M.S.
Director, Business Development
Cambridge Healthtech Institute

Phone: 781-972-5431
Email: jvacca@healthtech.com